Liminatus Pharma, Inc.

LIMN · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
22
SEC Filings

Business Summary

. 1 Item 1A. Risk Factors . 14 Item 1B. Unresolved Staff Comments . 14 Item 1C. Cybersecurity . 14 Item 2. Properties . 15 Item 3. Legal Proceedings . 15 Item 4. Mine Safety Disclosures . 15 PART II 16 Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities . 16 Item 6. [Reserved] 16 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations . 17 Item 7A. Quantitative and Qualitative Disclosures About M...

Next Earnings

Q2 FY2026 — expected 2026-08-13

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionLIMNdiscussed_in_filing Artificial Intelligence
topic_mentionLIMNdiscussed_in_filing Cybersecurity
topic_mentionLIMNdiscussed_in_filing Trusted Computing
topic_mentionLIMNdiscussed_in_filing Blockchain & Crypto
topic_mentionLIMNdiscussed_in_filing Regulation
topic_mentionLIMNdiscussed_in_filing Automotive
topic_mentionLIMNdiscussed_in_filing Healthcare & Bio
topic_mentionLIMNdiscussed_in_filing Networking
topic_mentionLIMNdiscussed_in_filing Artificial Intelligence
topic_mentionLIMNdiscussed_in_filing Cybersecurity
topic_mentionLIMNdiscussed_in_filing Trusted Computing
topic_mentionLIMNdiscussed_in_filing Blockchain & Crypto
topic_mentionLIMNdiscussed_in_filing Regulation
topic_mentionLIMNdiscussed_in_filing Automotive
topic_mentionLIMNdiscussed_in_filing Healthcare & Bio
topic_mentionLIMNdiscussed_in_filing Networking
topic_mentionLIMNdiscussed_in_filing Artificial Intelligence
topic_mentionLIMNdiscussed_in_filing Cybersecurity
topic_mentionLIMNdiscussed_in_filing Trusted Computing
topic_mentionLIMNdiscussed_in_filing Blockchain & Crypto

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-312025-12-310001104659-26-037933EDGAR46K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-142025-09-300001104659-25-111651EDGAR20K words
2025-10-062025-06-300001104659-25-096872EDGAR—
2025-06-022025-03-310001410578-25-001388EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-040001104659-26-023467EDGAR14K words
2026-02-180001104659-26-017134EDGAR—
2026-02-090001104659-26-012016EDGAR—
2026-01-260001104659-26-006619EDGAR—
2025-11-250001104659-25-116049EDGAR—
2025-08-250001104659-25-082579EDGAR—
2025-08-140001104659-25-078577EDGAR—
2025-07-170001104659-25-068670EDGAR—
2025-07-110001104659-25-067444EDGAR—
2025-07-030001104659-25-065663EDGAR—

22 total filings indexed. 8 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001971387
TickerLIMN
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 1d21901f5f944498d67d635e32d773ce8ee807d78514e8e8c88c36a5c39ca322
parent: ab808998adbbcdc3c19dfd9fb46ffe08a365dd70e6291e4a750c739d1afc2cf6
content hash: 67f73e6ab38cc0ae7f93709db0b27b1bb9192cd26ad28db1a91cdef1a06e7066
signed: 2026-04-13T04:46:02.590Z
sources: 4 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf